| scholarly article | Q13442814 |
| P2093 | author name string | M Guillaume Wientjes | |
| Jessie L-S Au | |||
| Ze Lu | |||
| Max Tsai | |||
| P2860 | cites work | Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems | Q30476025 |
| Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G | Q33335882 | ||
| The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review | Q33351403 | ||
| Clinical pharmacokinetics of depot leuprorelin | Q34135364 | ||
| Determinants of drug delivery and transport to solid tumors | Q34328553 | ||
| Intraperitoneal therapy for peritoneal cancer | Q34789701 | ||
| Biodegradable microspheres for protein delivery | Q35184855 | ||
| Drug delivery and transport to solid tumors | Q35563687 | ||
| Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment | Q36388620 | ||
| Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming | Q36848111 | ||
| Intraperitoneal therapy in the management of ovarian carcinoma | Q36987747 | ||
| Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel | Q37415150 | ||
| Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer | Q37415227 | ||
| Biodegradable polymers as biomaterials | Q38572825 | ||
| Pharmacokinetic principles of locoregional chemotherapy. | Q40730218 | ||
| Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study | Q40804158 | ||
| Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers | Q43638499 | ||
| Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine | Q43866655 | ||
| In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres | Q44008125 | ||
| Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method | Q44273102 | ||
| The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid) | Q47418853 | ||
| Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. | Q50512108 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study | Q67520718 | ||
| Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration | Q68100402 | ||
| Pharmacokinetics of carboplatin after intraperitoneal administration | Q68126770 | ||
| Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide | Q69745676 | ||
| Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally | Q71507617 | ||
| Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest | Q73358276 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Intraperitoneal chemotherapy for ovarian cancer | Q83150235 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacodynamics | Q725307 |
| P304 | page(s) | 737-744 | |
| P577 | publication date | 2013-09-20 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics | |
| P478 | volume | 172 |
| Q38609620 | Advancing drug delivery systems for the treatment of multiple sclerosis |
| Q38739520 | Inducing G2/M Cell Cycle Arrest and Apoptosis through Generation Reactive Oxygen Species (ROS)-Mediated Mitochondria Pathway in HT-29 Cells by Dentatin (DEN) and Dentatin Incorporated in Hydroxypropyl-β-Cyclodextrin (DEN-HPβCD). |
| Q92617881 | Pharmacokinetic problems in peritoneal drug administration: an update after 20 years |
| Q38717127 | Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier |
| Q43621286 | Sustained-releasing hollow microparticles with dual-anticancer drugs elicit greater shrinkage of tumor spheroids. |
| Q37254024 | Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer Treatment |
| Q37714442 | Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors |
| Q27687617 | Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer |
Search more.